CompanyDrug

Henlius Completes First Dosing in Global Phase III Study for HanSiZhuang in LS-SCLC

CompanyDeals

Singular Medical Secures Series B+ Funding for Cardiac Device Development

CompanyDrug

Boehringer Ingelheim Enrolls First Patient in Phase II/III Study for BI 907828

CompanyDrug

Vcanbio’s Stem Cell Therapy VUM02 Accepted for Clinical Trial Review

CompanyDrug

CanSino Biologics’ mRNA Vaccine CS-2034 Shows Positive Safety and Immunogenicity Data

CompanyDeals

Mindray Partners with BOMImed for Exclusive Canadian Sales and Service

CompanyDeals

Simnova Partners with Orna Therapeutics for In Situ CAR Therapies

Company

Aurisco Partners with Cytiva to Build Oligonucleotide Production Plant

CompanyDrug

Jiangsu Aidea’s ACC007 Approved by NMPA for HIV-1 Treatment

CompanyDeals

WuXi Biologics and GSK Ink Licensing Agreement for T-Cell Engaging Antibodies

CompanyDeals

Antengene Acquires Full Rights to Calithera’s CD73 Inhibitor CB-708

CompanyDrug

Haisco’s EGFR-PROTAC HSK40118 Accepted for Review by China’s NMPA